ASND

Ascendis Pharma A Stock Analysis

AI Rating

Good
  • Quality6/10
  • Growth↑ 7/10
  • Momentum↑ 7/10
Ascendis Pharma A sales and earnings growth
ASND Growth
Good
  • Revenue Y/Y↑ 98.03%
  • EPS Y/Y↑ 42.42%
  • FCF Y/Y↑ 114.81%
Ascendis Pharma A gross and profit margin trends
ASND Profitability
Neutral
  • Gross margin ↑ 86.80%
  • EPS margin↓ -31.70%
  • ROIC↓ -0.90%
Ascendis Pharma A net debt vs free cash flow
ASND Risk
Great
  • Debt / Equity↓ -6.9
  • Debt / FCF↑ 11.3
  • Interest coverage↓ 0.0

Ascendis Pharma A stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗